SHR-168442

N/A

Report date: 2022/01/12 14:19:57
NME

Base Information

Drug NameSHR-168442
Drug Alias NameSHR-168442
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A